glp 1 peptide tirzepatide Tirzepatide 10mg — GLP-1/GIP Dual-Agonist

If all other chronic diseases are treated with multiple drugs, why not type 1 diabetes? Other challenges in accessing adjunctive therapies Insurance coverage Most people with type 1 have a challenging time getting insurance coverage for adjunctive therapies, though some are able to come up with creative workarounds

Stimulant-containing supplements marketed for weight loss or energy enhancement (containing caffeine, synephrine, or yohimbine) should be avoided

This flexibility reduces both side effects during escalation and the likelihood of under-treatment that leads to weight gain

[Google Scholar] 80.Riaz U., Kharal M.A., Murtaza G., uz Zaman Q., Javaid S., Malik H.A., Aziz H., Abbas Z

RESULTS: Overall, 3417 participants underwent randomization